
Hypervascular pancreatic metastasis: an easy imaging diagnostic?
Author(s) -
Ioana Gabriela Lupescu,
Mirela Boroş,
Florinela Ștefănescu
Publication year - 2020
Publication title -
oncolog-hematolog.ro
Language(s) - English
Resource type - Journals
eISSN - 2066-8716
pISSN - 2066-8260
DOI - 10.26416/onhe.52.3.2020.3711
Subject(s) - medicine , pancreatic carcinoma , radiology , magnetic resonance imaging , differential diagnosis , metastasis , pathological , nuclear medicine , pancreatic cancer , leiomyosarcoma , cancer , pathology
Learning objectives. To review the computed tomograpy (CT) and magnetic resonance imaging (MRI) features of hypervascular pancreatic metastases (HPM). To discuss the main differential diagnosis of HPM. Materials and method. We retrospectively analyzed images from the CT and MRI evaluations of six patients who were diagnosed with HPM by morphopathological examination in the last ten years. Results. In our study, hypervascular pancreatic metastases corresponded to renal cell carcinoma, breast carcinoma and uterine leiomyosarcoma. In non-enhanced CT (NECT), all lesions were isodense or slightly hypodense. After i.v. injection of contrast medium (CM), hypervascular pancreatic metastases have displayed an early arterial phase enhancement, followed by rapid washout in the portal and delayed phases images. Contrast-enhanced CT showed for pancreatic metastases from uterine leiomyosarcoma a gradual enhancement. The common appearance in MRI for HPM was hypointense in T1 weighted image (wi), heterogeneous aspect in T2 wi or moderately hyperintense signal with restricted diffusion. After Gd-based CM i.v. injection, HPM showed the same dynamic as in CT evaluation. Conclusions. HPM may create a diagnostic challenge, therefore the pathological examination remains essential and represents the gold standard for the final diagnosis.